Vanguard Group Inc

13F Holdings History for BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO)

Symbol: BBIO on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 16.5M shares
Security Ownership: 8.68%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share (BBIO)

2025-07-29 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 16.5M shares of BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share (BBIO). This represents 8.68% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	8.68%		$575M	16.5M			$34.85	13G/A	6/30/2025	29 Jul 2025 11:20:32

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.01%	+0%	$874M	16.8M	+347,074	+2.11%	$51.94	Q3 2025
6/30/2025	0.01%	+0%	$712M	16.5M	+1,584,840	+10.6%	$43.18	Q2 2025
3/31/2025	0.01%	0%	$515M	14.9M	-177,770		$34.57	Q1 2025
12/31/2024	0.01%	+0%	$414M	15.1M	+879,059	+6.19%	$27.44	Q4 2024
9/30/2024	0.01%	+0%	$362M	14.2M	+144,108	+1.03%	$25.46	Q3 2024
6/30/2024	0.01%	+0%	$356M	14.1M	+832,622	+6.3%	$25.33	Q2 2024
3/31/2024	0.01%	+0%	$409M	13.2M	+421,832	+3.3%	$30.92	Q1 2024
12/31/2023	0.01%	+0%	$517M	12.8M	+1,524,313	+13.5%	$40.37	Q4 2023
9/30/2023	0.01%	0%	$297M	11.3M	-409,016	-3.5%	$26.37	Q3 2023
6/30/2023	0%	0%	$201M	11.7M	-378,259	-3.14%	$17.20	Q2 2023
3/31/2023	0.01%	+0%	$200M	12.1M	+1,471,801	+13.9%	$16.58	Q1 2023
12/31/2022	0%	+0%	$80.7M	10.6M	+587,184	+5.87%	$7.62	Q4 2022
9/30/2022	0%	+0%	$99.4M	10M	+108,734	+1.1%	$9.94	Q3 2022
6/30/2022	0%	+0%	$89.9M	9.9M	+471,425	+5%	$9.08	Q2 2022
3/31/2022	0%	+0%	$95.7M	9.42M	+92,429	+0.99%	$10.15	Q1 2022
12/31/2021	0%	0%	$156M	9.33M	-103,729	-1.1%	$16.68	Q4 2021
9/30/2021	0.01%	0%	$442M	9.44M	-1,893,717	-16.7%	$46.87	Q3 2021
6/30/2021	0.02%	+0%	$691M	11.3M	+1,987,943	+21.3%	$60.96	Q2 2021
3/31/2021	0.02%	+0.01%	$575M	9.34M	+2,899,874	+45%	$61.60	Q1 2021
12/31/2020	0.01%	+0%	$458M	6.44M	+146,194	+2.32%	$71.11	Q4 2020
9/30/2020	0.01%	+0%	$236M	6.3M	+508,600	+8.79%	$37.52	Q3 2020
6/30/2020	0.01%	+0%	$189M	5.79M	+3,417,387	+144%	$32.61	Q2 2020
3/31/2020	0%	+0%	$68.7M	2.37M	+228,135	+10.7%	$29.00	Q1 2020
12/31/2019	0%	+0%	$75M	2.14M	+548,046	+34.4%	$35.05	Q4 2019
9/30/2019	0%	+0%	$34.2M	1.59M	+1,505,668	+1725%	$21.47	Q3 2019
6/30/2019	0%	+0%	$2.35M	87.3K	+87,282	NEW	$26.97	Q2 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.